Sca-1 + cells from fetal heart with high aldehyde dehydrogenase activity exhibit enhanced gene expression for self-renewal, proliferation, and survival

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Dey, Devaveena ^a   Pan, Guodong ^b   Varma, Nadimpalli Ravi S ^b   Palaniyandi, Suresh Selvaraj ^b,c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c STANFORD UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; CELL CULTURE; CELL PROLIFERATION; CELLS; ENZYME ACTIVITY; ENZYMES; GENE EXPRESSION; GENES; HISTOLOGY; STEM CELLS; TISSUE;

ALDEHYDE DEHYDROGENASE; BIOCHEMICAL ASSAY; ENHANCED GENE EXPRESSION; FETAL CELLS; FETAL HEART; FETAL ORGANS; SELF RENEWAL; STEM CELL ANTIGEN-1;

CYTOLOGY;

ALDEHYDE DEHYDROGENASE ISOENZYME 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PROTEIN ISL1; PROTEIN MEF2C; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; ALDEHYDE DEHYDROGENASE; ALDH1A1 PROTEIN, HUMAN; KI 67 ANTIGEN; PROTEIN BCL 2;

ARTICLE; CELL DEATH; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS BY BODY ANATOMY; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS HEART; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; UPREGULATION; WESTERN BLOTTING; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOMAGNETIC SEPARATION; METABOLISM; STEM CELL;

ALDEHYDE DEHYDROGENASE; CELL PROLIFERATION; FETAL HEART; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOMAGNETIC SEPARATION; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; STEM CELLS;

EID: 84925635272     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/730683     Document Type: Article

References (28)

1. H. Wang, H. Chen, B. Feng et al., "Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue," BMC Biotechnology, vol. 14, no. 1, article 75, 2014.
2. H. Oh, S. B. Bradfute, T. D. Gallardo et al., "Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313-12318, 2003.
3. T. Nagai, K. Matsuura, and I. Komuro, "Cardiac side population cells and sca-1-positive cells,"Methods inMolecular Biology, vol. 1036, pp. 63-74, 2013.
4. A. M. Smits, P. van Vliet, C. H. Metz et al., "Human cardiomyocyte progenitor cells differentiate into functionalmature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology," Nature Protocols, vol. 4, no. 2, pp. 232-243, 2009.
5. E. Chavakis, M. Koyanagi, and S. Dimmeler, "Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back," Circulation, vol. 121, no. 2, pp. 325-335, 2010.
6. C.-H. Chen, G. R. Budas, E. N. Churchill, M.-H. Disatnik, T. D. Hurley, and D. Mochly-Rosen, "Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart," Science, vol. 321, no. 5895, pp. 1493-1495, 2008.
7. R. W. Storms, A. P. Trujillo, J. B. Springer et al., "Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9118-9123, 1999.
8. P. E. Burger, R. Gupta, X. Xiong et al., "High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells," Stem Cells, vol. 27, no. 9, pp. 2220-2228, 2009.
9. A. E. Balber, "Concise review: aldehyde dehydrogenase bright stem and progenitor cell populations from normal tissues: characteristics, activities, and emerging uses in regenerative medicine," Stem Cells, vol. 29, no. 4, pp. 570-575, 2011.
10. J. I. Ikeda, S. Mamat, T. Tian et al., "Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells," Laboratory Investigation, vol. 92, no. 4, pp. 606-614, 2012.
11. R. Lindahl, "Aldehyde dehydrogenases and their role in carcinogenesis," Critical Reviews in Biochemistry and Molecular Biology, vol. 27, no. 4-5, pp. 283-335, 1992.
12. L. Armstrong, M. Stojkovic, I. Dimmick et al., "Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity," Stem Cells, vol. 22, no. 7, pp. 1142-1151, 2004.
13. T. Gentry, E. Deibert, S. J. Foster, R. Haley, J. Kurtzberg, and A. E. Balber, "Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood," Cytotherapy, vol. 9, no. 6, pp. 569-576, 2007.
14. T. Gentry, S. Foster, L. Winstead, E. Deibert, M. Fiordalisi, and A. Balber, "Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy," Cytotherapy, vol. 9, no. 3, pp. 259-274, 2007.
15. B. J. Capoccia, D. L. Robson, K. D. Levac et al., "Revascularization of ischemic limbs after transplantation of human bone marrowcellswith high aldehyde dehydrogenase activity," Blood, vol. 113, no. 21, pp. 5340-5351, 2009.
16. D.M. Putman, K. Y. Liu, H. C. Broughton, G. I. Bell, and D. A. Hess, "Umbilical cord blood-derived aldehyde dehydrogenaseexpressing progenitor cells promote recovery from acute ischemic injury," StemCells, vol. 30, no. 10, pp. 2248-2260, 2012.
17. L. H. Keller, "Bone marrow-derived aldehyde dehydrogenasebright stem and progenitor cells for ischemic repair," Congestive Heart Failure, vol. 15, no. 4, pp. 202-206, 2009.
18. R. Mishra, K. Vijayan, E. J. Colletti et al., "Characterization and functionality of cardiac progenitor cells in congenital heart patients," Circulation, vol. 123, no. 4, pp. 364-373, 2011.
19. D. L. Simpson, R. Mishra, S. Sharma, S. K. Goh, S. Deshmukh, and S. Kaushal, "A strong regenerative ability of cardiac stem cells derived from neonatal hearts," Circulation, vol. 126, no. 11, supplement 1, pp. S46-S53, 2012.
20. D. G. Edmondson, G. E. Lyons, J. F. Martin, and E. N. Olson, "Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis," Development, vol. 120, no. 5, pp. 1251-1263, 1994.
21. J. Domen, S. H. Cheshier, and I. L. Weissman, "The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of BCL-2 increases both their number and repopulation potential,"The Journal of Experimental Medicine, vol. 191, no. 2, pp. 253-263, 2000.
22. J. Domen and I. L. Weissman, "Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other," The Journal of Experimental Medicine, vol. 192, no. 12, pp. 1707-1718, 2000.
23. C. S. Potten, "Stemcells in gastrointestinal epithelium: numbers, characteristics and death," Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 353, no. 1370, pp. 821-830, 1998.
24. E. K. Nishimura, S. R. Granter, and D. E. Fisher, "Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche," Science, vol. 307, no. 5710, pp. 720-724, 2005.
25. L. Wei, L. Cui, B. J. Snider et al., "Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia," Neurobiology of Disease, vol. 19, no. 1-2, pp. 183-193, 2005.
26. C. S. Sondergaard, D. A. Hess, D. J. Maxwell et al., "Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in amodel of acutemyocardial infarction," Journal of Translational Medicine, vol. 8, article 24, 2010.
27. E. C. Perin, G. V. Silva, Y. Zheng et al., "Randomized, doubleblind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure,"The AmericanHeart Journal, vol. 163, no. 3, pp. 415-421, 2012.
28. E. C. Perin, G. Silva, A. Gahremanpour et al., "A randomized, controlled study of autologous therapy with bone marrowderived aldehyde dehydrogenase bright cells in patients with critical limb ischemia," Catheterization and Cardiovascular Interventions, vol. 78, no. 7, pp. 1060-1067, 2011.